Frederick Gerald Wasserman, Director at Marker Therapeutics, Inc. (MRKR), bought 10,000 shares at $2.41 ($24K) on 2021-05-18, disclosed to the SEC on 2021-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DLHC | SELL | 2018-06-08 | $70K | — | Filing → |
| MAMS | SELL | 2018-05-30 | $44K | — | Filing → |
| MAMS | SELL | 2018-05-21 | $37K | — | Filing → |